United States In-Situ Hybridization Market Report & Forecast 2021-2027
Table of Contents1 Introduction to Research & Analysis Reports
1.1 In-Situ Hybridization Market Definition
1.2 Market Segments
1.2.1 Segment by Type
1.2.2 Segment by Application
1.3 United States In-Situ Hybridization Market Overview
1.4 Methodology & Sources of Information
1.4.1 Research Methodology
1.4.2 Research Process
1.4.3 Base Year
2 United States In-Situ Hybridization Overall Market Size
2.1 United States In-Situ Hybridization Market Size: 2021 VS 2027
2.2 United States In-Situ Hybridization Revenue, Prospects & Forecasts: 2016-2027
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top In-Situ Hybridization Players in United States Market
3.2 Top United States In-Situ Hybridization Companies Ranked by Revenue
3.3 United States In-Situ Hybridization Revenue by Companies
3.4 Top 3 and Top 5 In-Situ Hybridization Companies in United States Market, by Revenue in 2020
3.5 Companies In-Situ Hybridization Product Type
3.6 Tier 1, Tier 2 and Tier 3 In-Situ Hybridization Players in United States Market
3.6.1 List of Tier 1 In-Situ Hybridization Companies in United States
3.6.2 List of Tier 2 and Tier 3 In-Situ Hybridization Companies in United States
4 Sights by Type
4.1 Overview
4.1.1 By Type - United States In-Situ Hybridization Market Size Markets, 2021 & 2027
4.1.2 Radioactive isotopes
4.1.3 Non-radioactive labels
4.2 By Type - United States In-Situ Hybridization Revenue & Forecasts
4.2.1 By Type - United States In-Situ Hybridization Revenue, 2016-2021
4.2.2 By Type - United States In-Situ Hybridization Revenue, 2022-2027
4.2.3 By Type - United States In-Situ Hybridization Revenue Market Share, 2016-2027
5 Sights by Application
5.1 Overview
5.1.1 By Application - United States In-Situ Hybridization Market Size, 2021 & 2027
5.1.2 Cancer Diagnosis
5.1.3 Immunology
5.1.4 Neuroscience
5.1.5 Cytology
5.1.6 Infectious Diseases
5.2 By Application - United States In-Situ Hybridization Revenue & Forecasts
5.2.1 By Application - United States In-Situ Hybridization Revenue, 2016-2021
5.2.2 By Application - United States In-Situ Hybridization Revenue, 2022-2027
5.2.3 By Application - United States In-Situ Hybridization Revenue Market Share, 2016-2027
6 In-Situ Hybridization Companies Profiles
6.1 Abbott Laboratories
6.1.1 Abbott Laboratories Company Details
6.1.2 Abbott Laboratories Business Overview
6.1.3 Abbott Laboratories In-Situ Hybridization Introduction
6.1.4 Abbott Laboratories In-Situ Hybridization Revenue in United States Market (2016-2021)
6.1.5 Abbott Laboratories Recent Developments
6.2 F. Hoffmann-La Roche
6.2.1 F. Hoffmann-La Roche Company Details
6.2.2 F. Hoffmann-La Roche Business Overview
6.2.3 F. Hoffmann-La Roche In-Situ Hybridization Introduction
6.2.4 F. Hoffmann-La Roche In-Situ Hybridization Revenue in United States Market (2016-2021)
6.2.5 F. Hoffmann-La Roche Recent Developments
6.3 Leica Biosystems Nussloch
6.3.1 Leica Biosystems Nussloch Company Details
6.3.2 Leica Biosystems Nussloch Business Overview
6.3.3 Leica Biosystems Nussloch In-Situ Hybridization Introduction
6.3.4 Leica Biosystems Nussloch In-Situ Hybridization Revenue in United States Market (2016-2021)
6.3.5 Leica Biosystems Nussloch Recent Developments
6.4 Agilent Technologies
6.4.1 Agilent Technologies Company Details
6.4.2 Agilent Technologies Business Overview
6.4.3 Agilent Technologies In-Situ Hybridization Introduction
6.4.4 Agilent Technologies In-Situ Hybridization Revenue in United States Market (2016-2021)
6.4.5 Agilent Technologies Recent Developments
6.5 Thermo Fisher Scientific
6.5.1 Thermo Fisher Scientific Company Details
6.5.2 Thermo Fisher Scientific Business Overview
6.5.3 Thermo Fisher Scientific In-Situ Hybridization Introduction
6.5.4 Thermo Fisher Scientific In-Situ Hybridization Revenue in United States Market (2016-2021)
6.5.5 Thermo Fisher Scientific Recent Developments
6.6 Merck
6.6.1 Merck Company Details
6.6.2 Merck Business Overview
6.6.3 Merck In-Situ Hybridization Introduction
6.6.4 Merck In-Situ Hybridization Revenue in United States Market (2016-2021)
6.6.5 Merck Recent Developments
6.7 PerkinElmer
6.7.1 PerkinElmer Company Details
6.7.2 PerkinElmer Business Overview
6.7.3 PerkinElmer In-Situ Hybridization Introduction
6.7.4 PerkinElmer In-Situ Hybridization Revenue in United States Market (2016-2021)
6.7.5 PerkinElmer Recent Developments
6.8 Exiqon A/S
6.8.1 Exiqon A/S Company Details
6.8.2 Exiqon A/S Business Overview
6.8.3 Exiqon A/S In-Situ Hybridization Introduction
6.8.4 Exiqon A/S In-Situ Hybridization Revenue in United States Market (2016-2021)
6.8.5 Exiqon A/S Recent Developments
6.9 BioGenex Laboratories
6.9.1 BioGenex Laboratories Company Details
6.9.2 BioGenex Laboratories Business Overview
6.9.3 BioGenex Laboratories In-Situ Hybridization Introduction
6.9.4 BioGenex Laboratories In-Situ Hybridization Revenue in United States Market (2016-2021)
6.9.5 BioGenex Laboratories Recent Developments
6.10 Advanced Cell Diagnostics
6.10.1 Advanced Cell Diagnostics Company Details
6.10.2 Advanced Cell Diagnostics Business Overview
6.10.3 Advanced Cell Diagnostics In-Situ Hybridization Introduction
6.10.4 Advanced Cell Diagnostics In-Situ Hybridization Revenue in United States Market (2016-2021)
6.10.5 Advanced Cell Diagnostics Recent Developments
6.11 Bio SB
6.11.1 Bio SB Company Details
6.11.2 Bio SB Business Overview
6.11.3 Bio SB In-Situ Hybridization Introduction
6.11.4 Bio SB In-Situ Hybridization Revenue in United States Market (2016-2021)
6.11.5 Bio SB Recent Developments
7 Conclusion
8 Appendix
8.1 Note
8.2 Examples of Clients
8.3 Author Details
8.4 Disclaimer
List of TablesTable 1. In-Situ Hybridization Market Opportunities & Trends in United States Market
Table 2. In-Situ Hybridization Market Drivers in United States Market
Table 3. In-Situ Hybridization Market Restraints in United States Market
Table 4. Key Players of In-Situ Hybridization in United States Market
Table 5. Top In-Situ Hybridization Players in United States Market, Ranking by Revenue (2019)
Table 6. United States In-Situ Hybridization Revenue by Companies, (US$, Mn), 2016-2021
Table 7. United States In-Situ Hybridization Revenue Share by Companies, 2016-2021
Table 8. Companies In-Situ Hybridization Product Type
Table 9. List of Tier 1 In-Situ Hybridization Companies, Revenue (US$, Mn) in 2020 and Market Share
Table 10. List of Tier 2 and Tier 3 In-Situ Hybridization Companies, Revenue (US$, Mn) in 2020 and Market Share
Table 11. By Type - United States In-Situ Hybridization Revenue, (US$, Mn), 2021 & 2027
Table 12. By Type - United States In-Situ Hybridization Revenue (US$, Mn), 2016-2021
Table 13. By Type - United States In-Situ Hybridization Revenue (US$, Mn), 2022-2027
Table 14. By Application - United States In-Situ Hybridization Revenue, (US$, Mn), 2021 VS 2027
Table 15. By Application - United States In-Situ Hybridization Revenue (US$, Mn), 2016-2021
Table 16. By Application - United States In-Situ Hybridization Revenue (US$, Mn), 2022-2027
Table 17. Abbott Laboratories Company Details
Table 18. Abbott Laboratories Business Overview
Table 19. Abbott Laboratories In-Situ Hybridization Product
Table 20. Abbott Laboratories In-Situ Hybridization Revenue in United States Market (2016-2021) & (US$ Million)
Table 21. Abbott Laboratories Recent Developments
Table 22. F. Hoffmann-La Roche Company Details
Table 23. F. Hoffmann-La Roche Business Overview
Table 24. F. Hoffmann-La Roche In-Situ Hybridization Product
Table 25. F. Hoffmann-La Roche In-Situ Hybridization Revenue in United States Market (2016-2021) & (US$ Million)
Table 26. F. Hoffmann-La Roche Recent Developments
Table 27. Leica Biosystems Nussloch Company Details
Table 28. Leica Biosystems Nussloch Business Overview
Table 29. Leica Biosystems Nussloch In-Situ Hybridization Product
Table 30. Leica Biosystems Nussloch In-Situ Hybridization Revenue in United States Market (2016-2021) & (US$ Million)
Table 31. Leica Biosystems Nussloch Recent Developments
Table 32. Agilent Technologies Company Details
Table 33. Agilent Technologies Business Overview
Table 34. Agilent Technologies In-Situ Hybridization Product
Table 35. Agilent Technologies In-Situ Hybridization Revenue in United States Market (2016-2021) & (US$ Million)
Table 36. Agilent Technologies Recent Developments
Table 37. Thermo Fisher Scientific Company Details
Table 38. Thermo Fisher Scientific Business Overview
Table 39. Thermo Fisher Scientific In-Situ Hybridization Product
Table 40. Thermo Fisher Scientific In-Situ Hybridization Revenue in United States Market (2016-2021) & (US$ Million)
Table 41. Thermo Fisher Scientific Recent Developments
Table 42. Merck Company Details
Table 43. Merck Business Overview
Table 44. Merck In-Situ Hybridization Product
Table 45. Merck In-Situ Hybridization Revenue in United States Market (2016-2021) & (US$ Million)
Table 46. Merck Recent Developments
Table 47. PerkinElmer Company Details
Table 48. PerkinElmer Business Overview
Table 49. PerkinElmer In-Situ Hybridization Product
Table 50. PerkinElmer In-Situ Hybridization Revenue in United States Market (2016-2021) & (US$ Million)
Table 51. PerkinElmer Recent Developments
Table 52. Exiqon A/S Company Details
Table 53. Exiqon A/S Business Overview
Table 54. Exiqon A/S In-Situ Hybridization Product
Table 55. Exiqon A/S In-Situ Hybridization Revenue in United States Market (2016-2021) & (US$ Million)
Table 56. Exiqon A/S Recent Developments
Table 57. BioGenex Laboratories Company Details
Table 58. BioGenex Laboratories Business Overview
Table 59. BioGenex Laboratories In-Situ Hybridization Product
Table 60. BioGenex Laboratories In-Situ Hybridization Revenue in United States Market (2016-2021) & (US$ Million)
Table 61. BioGenex Laboratories Recent Developments
Table 62. Advanced Cell Diagnostics Company Details
Table 63. Advanced Cell Diagnostics Business Overview
Table 64. Advanced Cell Diagnostics In-Situ Hybridization Product
Table 65. Advanced Cell Diagnostics In-Situ Hybridization Revenue in United States Market (2016-2021) & (US$ Million)
Table 66. Advanced Cell Diagnostics Recent Developments
Table 67. Bio SB Company Details
Table 68. Bio SB Business Overview
Table 69. Bio SB In-Situ Hybridization Product
Table 70. Bio SB In-Situ Hybridization Revenue in United States Market (2016-2021) & (US$ Million)
Table 71. Bio SB Recent Developments
List of FiguresFigure 1. In-Situ Hybridization Segment by Type
Figure 2. In-Situ Hybridization Segment by Application
Figure 3. United States In-Situ Hybridization Market Overview: 2020
Figure 4. United States In-Situ Hybridization Market Size: 2021 VS 2027 (US$, Mn)
Figure 5. United States In-Situ Hybridization Revenue, 2016-2027 (US$, Mn)
Figure 6. The Top 3 and 5 Players Market Share by In-Situ Hybridization Revenue in 2020
Figure 7. By Type - United States In-Situ Hybridization Revenue Market Share, 2016-2027
Figure 8. By Application - United States In-Situ Hybridization Revenue Market Share, 2016-2027
Figure 9. Abbott Laboratories In-Situ Hybridization Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 10. F. Hoffmann-La Roche In-Situ Hybridization Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 11. Leica Biosystems Nussloch In-Situ Hybridization Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 12. Agilent Technologies In-Situ Hybridization Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 13. Thermo Fisher Scientific In-Situ Hybridization Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 14. Merck In-Situ Hybridization Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 15. PerkinElmer In-Situ Hybridization Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 16. Exiqon A/S In-Situ Hybridization Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 17. BioGenex Laboratories In-Situ Hybridization Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 18. Advanced Cell Diagnostics In-Situ Hybridization Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 19. Bio SB In-Situ Hybridization Revenue Year Over Year Growth (US$, Mn) & (2016-2021)